Induction of cyclooxygenase-2 and activation of nuclear factor-κB in myocardium of patients with congestive heart failure

Circulation

Volumn 98, Issue 2, 1998, Pages 100-103

  Wong, Samuel C Y ^a   Fukuchi, Mitsumasa ^a   Melnyk, Peter ^a   Rodger, Ian ^c   Giaid, Adel ^a,b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b GenPath Laboratories   (Canada)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Cardiomyopathy; Heart failure; Infarction; Myocardium

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0032516477     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.2.100     Document Type: Article

References (15)

1. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclo-oxygenase)-1 and -2. J Biol Chem. 1996;271: 33157-33160.
2. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclo-oxygenase-2 in MC3T3-E1 cells. J Biol Chem. 1995;270:31315-31320.
3. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
4. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
5. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN, Runge MS. Hypoxia induces cyclo-oxygenase-2 via the NF-kB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 1997;272:601-608.
6. Schror K, Hohlfeld TH. Inotropic actions of eicosanoids. Basic Res Cardiol. 1992;87:2-11.
7. Linssen MCJG, Engels W, Lemmens PJMR, Heijnen VVTH, Bilsen MV, Reneman RS, van der Vusse GJ. Production of arachidonic acid metabolites in adult rat cardiac myocytes, endothelial cells, and fibroblast-like cells. Am J Physiol. 1993;264(Heart Circ Physiol 33):H973-H982.
8. 2-alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo. Am J Physiol. 1996;40:H2197-H2208.
9. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.
10. Curtis MJ, Pugsley MK, Walker MJ. Endogenous chemical mediators of ventricular arrhythmias in ischemic heart disease. Cardiovasc Res. 1993; 27:703-719.
11. Liu SF, Newton R, Evans TW, Barnes PJ. Differential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci. 1996;90:301-306.
12. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J. 1994;302:723-727.
13. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure. N Engl J Med. 1982; 10:347-352.
14. Townend JN, Doran J, Lote CJ, Davies MK. Peripheral hemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interaction with captopril. Br Heart J. 1995;73:434-441.
15. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol. 1992;263(Heart Circ Physiol 32): H1963-H1966.